Jon-Paul Bingham

Dr. Jon-Paul Bingham

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2012 in Toxins
Verified
Journal Article
Open access
PDF file
ZBZachary L. Bergeron
Zachary L. Bergeron
JBJon-Paul Bingham
Jon-Paul Bingham
Scorpion toxins have been central to the investigation and understanding of the physiological role of potassium (K+) channels and their expansive function in membrane biophysics. As highly specific probes, toxins have revealed a great deal about channel structure and the correlation between mutations, altered regulation and a number of human pathologies. Radio- and fluorescently-labeled toxin isoforms have contributed to localization studies of channel subtypes in expressing cells, and have been further used in competitive displacement assays for the identification of additional novel ligands for use in research and medicine. Chimeric toxins have been designed from multiple peptide scaffolds to probe channel isoform specificity, while advanced epitope chimerization has aided in the development of novel molecular therapeutics. Peptide backbone cyclization has been utilized to enhance therapeutic efficiency by augmenting serum stability and toxin half-life in vivo as a number of K+-channel isoforms have been identified with essential roles in disease states ranging from HIV, T-cell mediated autoimmune disease and hypertension to various cardiac arrhythmias and Malaria. Bioengineered scorpion toxins have been monumental to the evolution of channel science, and are now serving as templates for the development of invaluable experimental molecular therapeutics.

12 September 2014 in Molecules
Verified
Journal Article
Open access
PDF file
PTParashar Thapa
Parashar Thapa
RZRui-Yang Zhang
Rui-Yang Zhang
VMVinay Menon
Vinay Menon
JBJon-Paul Bingham
Jon-Paul Bingham
The use of chemical ligation within the realm of peptide chemistry has opened various opportunities to expand the applications of peptides/proteins in biological sciences. Expansion and refinement of ligation chemistry has made it possible for the entry of peptides into the world of viable oral therapeutic drugs through peptide backbone cyclization. This progression has been a journey of chemical exploration and transition, leading to the dominance of native chemical ligation in the present advances of peptide/protein applications. Here we illustrate and explore the historical and current nature of peptide ligation, providing a clear indication to the possibilities and use of these novel methods to take peptides outside their typically defined boundaries.

1 January 2010 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
JBJon-Paul Bingham
Jon-Paul Bingham
EMErin Mitsunaga
Erin Mitsunaga
ZBZachary L. Bergeron
Zachary L. Bergeron

1 March 2018 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
RZRui-Yang Zhang
Rui-Yang Zhang
PTParashar Thapa
Parashar Thapa
MEMichael J. Espiritu
Michael J. Espiritu
VMVinay Menon
Vinay Menon
JBJon-Paul Bingham
Jon-Paul Bingham

10 August 2014 in International Journal of Peptide Research and Therapeutics
Verified
Journal Article
Closed access
PDF file
PTParashar Thapa
Parashar Thapa
MEMichael J. Espiritu
Michael J. Espiritu
CCChino Cabalteja
Chino Cabalteja
JBJon-Paul Bingham
Jon-Paul Bingham

4 November 2019 in Inflammopharmacology
Verified
Journal Article
Closed access
PDF file
RLRozalia Laczko
Rozalia Laczko
ACAndrew Young Chang
Andrew Young Chang
LWLindsey Watanabe
Lindsey Watanabe
MPMaria Petelo
Maria Petelo
KKKimberly Kahaleua
Kimberly Kahaleua
KCKatalin Csiszar
Katalin Csiszar